Interlaboratory study of quality control isolates for a broth microdilution method (Modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals

Journal of Clinical Microbiology

Volumn 44, Issue 12, 2006, Pages 4353-4356

  Ghannoum, M A ^a   Arthington Skaggs, B ^b   Chaturvedi, V ^c   Espinel Ingroff, A ^d   Pfaller, M A ^e   Rennie, R ^f   Rinaldi, M G ^g   Walsh, T J ^h  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c State of New York ^*  (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROX; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; POSACONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; DERMATOPHYTE; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; MICROBIAL SENSITIVITY TESTS; QUALITY CONTROL; REFERENCE STANDARDS;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; FUNGI; TRICHOPHYTON RUBRUM;

EID: 33845591155     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00688-06     Document Type: Article

References (6)

1. CLS1/NCCLS. 2001. Development of in vitro susceptibility testing criteria and quality control parameters: approved guideline, 2nd ed. NCCLS document M23-A2. NCCLS, Wayne, Pa.
2. CLSI/NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard. NCCLS document M38-A. NCCLS, Wayne, Pa.
3. Ghannoum, M. A., V. Chaturvedi, A. Espinel-Ingroff, M. A. Pfaller, M. G. Rinaldi, W. Lee-Yang, and D. W. Warnock. 2004. Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J. Clin. Microbiol. 42:2977-2979.
4. Jessup, C. J., J. Warner, N. Isham, I. Hasan, and M. A. Ghannoum. 2000. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J. Clin. Microbiol. 38:314-344.
5. Norris, H. A., B. E. Elewski, and M. A. Ghannoum. 2000. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J. Am. Acad. Dermatol. 40:S9-S13.
6. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi, C. R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J. Clin. Microbiol. 33:1104-1107.